Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction
Clinical trial NCT03549260 · COMPLETED
Trial details
- NCT number
- NCT03549260
- Sponsor
- LIB Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-22
- Primary completion
- 2018-11-09
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.